In addition, the versatility of the αFAP TMs and proven specific accumulation at FAP-expressing sites pave the way to a new era of cancer diagnostics and therapy for solid tumors and their immunosuppressive TME, in which one molecule could be used for diagnosis, tumor monitoring, and treatment involving both radiotherapeutic and immunotherapeutic approaches. This evidence concerns the gene AFAP1 and neoplasm.